Despite Halting Vaccine Trials, Johnson & Johnson Delivers Strong Earnings and Forecast

In the heat of a race with rivals such as Pfizer (PFE), Moderna (MRNA) and AstraZeneca (AZN) to develop a safe and effective vaccine for the coronavirus, Johnson & Johnson (JNJ) provided shareholders with strong insight on how the company has held up through uncertainty. This morning, the pharmaceutical powerhouse reported third-quarter earnings which beat

Read More ›

GenMark Gets Approval on Test that Distinguishes Between Flu, COVID-19 and More

More great news broke yesterday afternoon on the virus diagnosis front, which has sent investors running to their brokers and trading apps. Yesterday, the lab test manufacturer GenMark Diagnostics (GNMK) announced it was granted emergency use authorization by the FDA for its rapid molecular test that can distinguish between more than 20 different viruses and bacteria, including

Read More ›

Kamala Harris Helps Cannabis Industry Climb Back After Stagnant Growth

Ok, let’s be blunt (sorry). In a year defined by quarantines, lockdowns and record food-delivery sales, one could easily the stars would have aligned to send cannabis sales sky high (sorry, again). Instead, the industry finds itself riddled with regulatory delays, slower-than-expected retail store openings, and a persistently strong black market have all weighed on

Read More ›

In the Name of “Operation Warp Speed”, White House Overules FDA’s Vaccine Approval Guidelines

Launched back in 2020 after COVID-19 began taking a serious toll on America, Operation Warp Speed is an initiative the White House has pushed forward in partnership with the CDC, FDA, NIH, HHS and several other public and private groups including a number of pharmaceutical and biotech firms. The goal of Operation Warp Speed is

Read More ›

Inovio’s Pause in Vaccine Trials Sparks Selloff… But What Happened?

With about five biotech companies entering into late-stage trials for their respective coronavirus candidates already, Inovio Pharmaceuticals Inc. (INO) was already considered lagging behind in the race for a vaccine, despite gaining an impressive 300% on the year, with generally positive sentiments on the company’s progress, but then came today’s news… This morning, Inovio announced

Read More ›

Johnson & Johnson Emerges as Serious Competitor in “Operation Warp Speed”

Today, the pharmaceutical and consumer products giant, Johnson & Johnson (JNJ) announced its begun its phase three trial testing its potential coronavirus vaccine. Joining Moderna (MRNA), AstraZeneca (AZN) and Pfizer (PFE), J&J marks the fourth company as part of the White House’s “Operation Warp” speed to enter late-stage testing trials. Johnson & Johnson joined the

Read More ›

Market Overview